Latest Insider Transactions at Alteryx, Inc. (AYX)
This section provides a real-time view of insider transactions for Alteryx, Inc. (AYX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alteryx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alteryx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Anjali Joshi Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+27.54%
|
-
|
|
May 17
2023
|
Charles Cory Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+27.02%
|
-
|
|
May 17
2023
|
Eileen Schloss Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+31.09%
|
-
|
|
May 17
2023
|
Timothy I Maudlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+10.57%
|
-
|
|
May 17
2023
|
Daniel J Warmenhoven Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+24.73%
|
-
|
|
May 17
2023
|
Dean Stoecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+6.16%
|
-
|
|
May 17
2023
|
Dean Stoecker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,045
-1.31%
|
$39,710
$38.05 P/Share
|
|
May 17
2023
|
Ce Celia Morken Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,520
+24.73%
|
-
|
|
Mar 08
2023
|
Eileen Schloss Director |
SELL
Open market or private sale
|
Direct |
4,500
-40.12%
|
$292,500
$65.47 P/Share
|
|
Mar 07
2023
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,726
+18.24%
|
-
|
|
Mar 07
2023
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
43,726
+19.22%
|
-
|
|
Mar 07
2023
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
23,013
+16.63%
|
-
|
|
Mar 07
2023
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
51,780
+23.41%
|
-
|
|
Mar 07
2023
|
Mark Anderson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,068
+25.08%
|
-
|
|
Mar 07
2023
|
Chris Natali Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,506
+20.94%
|
-
|
|
Mar 01
2023
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,814
-7.17%
|
$702,910
$65.34 P/Share
|
|
Mar 01
2023
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,896
-6.88%
|
$1,098,240
$65.34 P/Share
|
|
Mar 01
2023
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,627
-3.56%
|
$365,755
$65.34 P/Share
|
|
Mar 01
2023
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,740
-4.88%
|
$308,100
$65.34 P/Share
|
|
Mar 01
2023
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,562
-2.94%
|
$231,530
$65.34 P/Share
|
|
Mar 01
2023
|
Chris Natali Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,265
-11.78%
|
$277,225
$65.34 P/Share
|
|
Feb 20
2023
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,326
+10.3%
|
$1,160,842
$67.01 P/Share
|
|
Feb 20
2023
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,326
+9.89%
|
$1,160,842
$67.01 P/Share
|
|
Feb 20
2023
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,240
+8.69%
|
$619,080
$67.01 P/Share
|
|
Feb 20
2023
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
17,326
+12.51%
|
$1,160,842
$67.01 P/Share
|
|
Jan 01
2023
|
Dean Stoecker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,379
-2.9%
|
$118,950
$50.67 P/Share
|
|
Jan 01
2023
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-1.1%
|
$48,450
$50.67 P/Share
|
|
Jan 01
2023
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,323
-0.98%
|
$66,150
$50.67 P/Share
|
|
Dec 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,820
-4.15%
|
$267,720
$46.3 P/Share
|
|
Dec 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-3.82%
|
$161,690
$46.3 P/Share
|
|
Dec 01
2022
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,380
-3.3%
|
$385,480
$46.3 P/Share
|
|
Dec 01
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,139
-3.54%
|
$236,394
$46.3 P/Share
|
|
Dec 01
2022
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,148
-2.03%
|
$98,808
$46.3 P/Share
|
|
Nov 30
2022
|
Paula Hansen President & CRO |
SELL
Open market or private sale
|
Direct |
6,500
-5.79%
|
$286,000
$44.1 P/Share
|
|
Sep 14
2022
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
25,380
+5.9%
|
-
|
|
Sep 14
2022
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,660
+8.17%
|
-
|
|
Sep 14
2022
|
Mark Anderson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,198
+34.74%
|
-
|
|
Sep 01
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,137
-3.41%
|
$308,220
$60.76 P/Share
|
|
Sep 01
2022
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,148
-1.88%
|
$128,880
$60.76 P/Share
|
|
Sep 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.48%
|
$68,760
$60.76 P/Share
|
|
Sep 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,148
-1.83%
|
$128,880
$60.76 P/Share
|
|
Aug 05
2022
|
Paula Hansen President & CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,750
-3.99%
|
$294,500
$62.53 P/Share
|
|
Aug 05
2022
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
9,579
+7.44%
|
-
|
|
Aug 05
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,249
-2.75%
|
$263,438
$62.53 P/Share
|
|
Aug 05
2022
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,579
+5.83%
|
-
|
|
Aug 05
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,715
-3.39%
|
$168,330
$62.53 P/Share
|
|
Aug 05
2022
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,474
+6.39%
|
-
|
|
Aug 05
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,054
-2.54%
|
$189,348
$62.53 P/Share
|
|
Aug 05
2022
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,158
+4.87%
|
-
|
|
Aug 05
2022
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,445
-17.64%
|
$1,577,590
$62.53 P/Share
|